Compare LNAI & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LNAI | MLSS |
|---|---|---|
| Founded | N/A | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.3M | 20.7M |
| IPO Year | N/A | 1995 |
| Metric | LNAI | MLSS |
|---|---|---|
| Price | $0.81 | $0.27 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.00 |
| AVG Volume (30 Days) | 256.6K | ★ 279.5K |
| Earning Date | 02-13-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $8,929,517.00 |
| Revenue This Year | N/A | $8.95 |
| Revenue Next Year | N/A | $7.51 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 0.59 |
| 52 Week Low | $0.63 | $0.22 |
| 52 Week High | $14.00 | $1.28 |
| Indicator | LNAI | MLSS |
|---|---|---|
| Relative Strength Index (RSI) | 48.05 | 43.29 |
| Support Level | $0.63 | $0.25 |
| Resistance Level | $1.12 | $0.29 |
| Average True Range (ATR) | 0.13 | 0.02 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 39.84 | 34.46 |
Lunai Bioworks Inc is a biopharmaceutical company. Through its subsidiaries, it is mainly focused on developing allogeneic cell and gene therapies to promote stronger immune system responses, potentially for long-term or life-long cancer remission in some of the deadliest cancers. The group is engaged in the development of RENB-DC11 and RENB-DC20 (potential cell therapeutic vaccine candidates for different types of cancer); a proprietary AI platform that analyzes genetics to provide earlier and more accurate cancer diagnosis; and machine learning pipelines that harmonize and analyze complex, heterogeneous datasets to uncover clinically actionable insights. The group's reportable segments are: RENB, BioSymetrics, and RENC. Geographically, it operates in the United States and Netherlands.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.